Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022

Clinical trials provide evidence that pre-exposure prophylaxis (PrEP) prevents HIV acquisition including through sharing of injection equipment among people who inject drugs (PWID). However, uptake among many populations at risk for HIV has been slow, particularly among PWID. We examined data from t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS and behavior 2024-06, Vol.28 (6), p.2089-2100
Hauptverfasser:	Suprasert, Bow, Tate, Moranda, Reagan, Danyion, Ruiz, Raul, Gao, Katherine, McNaughton, Katherine, Miller, Kassandra, Marr, Alexander, Taylor, Kelly D., Wilson, Erin C., McFarland, Willi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Anti-HIV Agents - administration & dosage Anti-HIV Agents - therapeutic use Clinical trials Consciousness Disease prevention Drug abuse Drugs Female Gays & lesbians Harm reduction Health care industry Health Knowledge, Attitudes, Practice Health Psychology Health services Heroin HIV HIV Infections - epidemiology HIV Infections - prevention & control Human immunodeficiency virus Humans Infectious Diseases Injection Male Medicine Medicine & Public Health Men Men who have sex with men Mens health Middle Aged Original Paper Patient Acceptance of Health Care - statistics & numerical data Pre-Exposure Prophylaxis Prophylaxis Public Health Risk-Taking San Francisco - epidemiology Sexually transmitted diseases STD Substance Abuse, Intravenous - complications Substance Abuse, Intravenous - epidemiology Surveillance Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!